Oct 26,2021

Digital health pioneer closes Series A funding round and attracts new investors

HelloBetter raises six million Euros to build the category leader in digital mental health. HelloBetter, a global leader in the field of e-mental health innovation, has closed a Series A funding round of …

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Oct 04,2021

GraphWear closes $20.5M Series B for a needle-free, nanotech-powered glucose monitor

GraphWear, a company pursuing needle-free approaches to glucose monitoring, has closed a $20.5 million Series B round. This Series B round is a vote of confidence by investors in GraphWear’s approach: to monitor key metrics in the body, like glucose, without breaking the skin at all.

FUNDING SERIES B

#rpm

View Analyst & Ambassador Comments
Go to original news
Oct 07,2021

Twin Health Raises $140Million Series C To Scale Its Groundbreaking Whole Body Digital Twin Service Enabling Reversal And Prevention Of Chronic Metabolic Disease

Twin Health (provider of metabolic disease solutions), makers of the Whole Body Digital Twin precision health service, announced $140 million in Series C funding as it scales its service in the U.S. and globally.

FUNDING SERIES C
View Analyst & Ambassador Comments
Go to original news
Nov 10,2021

Signos raises $13M Series A to give you real-time weight-loss advice based on your blood glucose levels

Weight-loss startup Signos is betting that you’re curious enough about the difference between our respective metabolisms to sign up for real-time glucose monitoring and alerts to keep you in shape. It turns out that GV believes that, too, to the tune of leading the company’s $13 million Series A round.

FUNDING SERIES A

#cgm

View Analyst & Ambassador Comments
Go to original news
Dec 02,2021

Digital Insulin Management Company Hygieia Closes on $17 Million Series B Investment Round

Funding will enable expansion of company’s AI-driven d-Nav technology, which automates real-time insulin dose recommendations for people with type 2 diabetes. Hygieia, a digital health company for insulin management, has closed on an initial $17 million Series B investment round, led by Israeli venture capital firm Firstime Ventures, and with participation from existing investors.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Jan 07,2020

Paris-based PKvitality snaps up €2.25 million to develop smartwatch for diabetes management

PKvitality, a French startup specialized in bio wearables, has snapped up €2.25 million via an agreement with Beurer GmBH, the German medical product and well-being company.

FUNDING SEED
View Analyst & Ambassador Comments
Go to original news
Jan 10,2020

Virta Health Raises $93 Million to Combat the $400B Type 2 Diabetes Epidemic and Expand Diabetes Reversal to Millions

Virta Health, the first company with a treatment to sustainably reverse type 2 diabetes (T2D) without medications or surgery, today announced that it has raised $93 million in Series C funding to combat the growing prevalence of T2D, bringing the total equity funding to $166 million.

FUNDING SERIES C
View Analyst & Ambassador Comments
Go to original news
Jan 13,2020

Bigfoot Biomedical® Announces Initial $45 Million of a Series C Financing Led by Abbott

Funds to Support Breakthrough Therapy for 6M People Living with Insulin-Requiring Type 1 and Type 2 Diabetes

FUNDING SERIES C
View Analyst & Ambassador Comments
Go to original news
Jan 14,2020

Oviva scores $21M Series B to bring its digital diabetes treatment to more of Europe

Oviva, the health tech startup that provides a digital solution for Type 2 diabetes treatment in Europe, has raised $21 million in Series B funding.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Feb 18,2020

Noom competitor OurPath rebrands as Second Nature, raises $10M Series A

Back in 2018, OurPath emerged as a startup in the U.K. tackling the problem of diabetes. Now rebranded as Second Nature, it has raised a fresh $10 million in Series A funding.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news